BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17727439)

  • 1. Bravo capsule for wireless 48-h pH monitoring: proposed algorithm for its placement.
    Marchese M; Spada C; Costamagna G
    Am J Gastroenterol; 2007 Sep; 102(9):2104-5; author reply 2106. PubMed ID: 17727439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
    Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
    Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
    Doma S; Paladugu S; Parkman HP; Friedenberg FK
    Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
    Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
    Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
    Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
    Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous wireless pH monitoring study overlooked.
    Hochman J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):607; author reply 607. PubMed ID: 18493221
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability and clinical utility of the Bravo pH capsule in children.
    Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
    J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bravo pH capsule system.
    Kwiatek MA; Pandolfino JE
    Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
    Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
    Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and utility of the Bravo pH capsule.
    Pandolfino JE; Kwiatek MA
    J Clin Gastroenterol; 2008; 42(5):571-8. PubMed ID: 18364590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wireless capsule pH monitoring: does it fulfil all expectations?
    Maerten P; Ortner M; Michetti P; Dorta G
    Digestion; 2007; 76(3-4):235-40. PubMed ID: 18174686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
    Kahrilas PJ; Pandolfino JE
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
    Carmona-Sánchez R; Solana-Sentíes S
    Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wireless upper esophageal monitoring for laryngopharyngeal reflux (LPR).
    Friedman M; Schalch P; Vidyasagar R; Kakodkar KA; Mazloom N; Joseph NJ
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):471-6. PubMed ID: 17765778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosisof GERD.
    Wenner J; Johansson J; Johnsson F; Oberg S
    Am J Gastroenterol; 2007 Sep; 102(9):1862-9. PubMed ID: 17509034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
    Domingues GR; Moraes-Filho JP; Domingues AG
    Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.